Role of heme Oxygenase-1 in low dose Radioadaptive response  by Bao, Lingzhi et al.
Redox Biology 8 (2016) 333–340Contents lists available at ScienceDirectRedox Biologyhttp://d
2213-23
n Corr
E-mjournal homepage: www.elsevier.com/locate/redoxResearch paperRole of heme Oxygenase-1 in low dose Radioadaptive response
Lingzhi Bao a, Jie Ma a,b, Guodong Chen a, Jue Hou a, Tom K. Hei c, K.N. Yu d,a, Wei Han a,e,n
a Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, China
b University of Science and Technology of China, Hefei, Anhui, China
c Center for Radiological Research, Columbia University, New York, NY, USA
d Department of Physics and Materials Science, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Hong Kong
e Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions and School for Radiological and Interdisciplinary Sciences
(RAD-X), Soochow University, Suzhou, Jiangsu, Chinaa r t i c l e i n f o
Article history:
Received 28 January 2016
Received in revised form
26 February 2016
Accepted 2 March 2016
Available online 3 March 2016
Keywords:
Heme Oxygenase 1
Radioadaptive response
Hemin
Znpp
Nrf2
Reactive oxidative speciesx.doi.org/10.1016/j.redox.2016.03.002
17/& 2016 The Authors. Published by Elsevier
espondence to: 350 Shushanghu Road, 23003
ail address: hanw@hfcas.ac.cn (W. Han).a b s t r a c t
Radioadaptive response (RAR) is an important phenomenon induced by low dose radiation. However, the
molecular mechanism of RAR is obscure. In this study, we focused on the possible role of heme oxy-
genase 1 (HO-1) in RAR. Consistent with previous studies, priming dose of X-ray radiation (1–10 cGy)
induced signiﬁcant RAR in normal human skin ﬁbroblasts (AG 1522 cells). Transcription and translation
of HO-1 was up-regulated more than two fold by a priming dose of radiation (5 cGy). Zinc proto-
porphyrin Ⅸ, a speciﬁc competitive inhibitor of HO-1, efﬁciently inhibited RAR whereas hemin, an in-
ducer of HO-1, could mimic priming dose of X-rays to induce RAR. Knocking down of HO-1 by trans-
fection of HO-1 siRNA signiﬁcantly attenuated RAR. Furthermore, the expression of HO-1 gene was
modulated by the nuclear factor (erythroid-derived 2)-like 2 (Nrf2), which translocated from cytoplasm
to nucleus after priming dose radiation and enhance the antioxidant level of cells.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Radioadaptive response (RAR) is characterized by a reduction of
radiobiological response in cells which have been pretreated with
a low-dose radiation followed by a subsequent higher challenging
dose [1]. Olivieri et al. were the ﬁrst to demonstrate that when
human lymphocytes were pre-cultured with [3H]thymidine, which
acted as a source of low-level chronic radiation, and were then
exposed to 1.5 Gy of x-rays at 5, 7, 9, or 11 h before ﬁxation, the
yield of chromatid aberrations was less than the sum of the in-
dividual yields of aberrations induced by [3H]thymidine and x-rays
alone [2]. In the past three decades, accumulated experimental
data have established the existence of such a response using a
variety of endpoints [3], such as sister chromatid exchanges, mi-
cronuclei (MN) induction and clonogenic survival [4–7]. Further-
more, RAR has been observed in many different organisms: bac-
teria, yeast, higher plants, insect cells, mammalian and human
cells in vitro, and animal models in vivo [8–10].
Up to now, however, the molecular basis for RAR remains not
clear. It is possible that RAR depends on the activation of DNA
repair and cell cycle regulation, or activation of antioxidant en-
zymes due to the oxidative stress caused by ionizing radiation.
Bravard et al. reported the activation of antioxidant enzymes suchB.V. This is an open access article u
1 Hefei, Anhui, PR China.as manganese superoxide dismutase, glutathione peroxidase and
catalase after administration of an initial low-dose radiation fol-
lowed by a subsequent high-dose radiation [11]. The increased
activities of these antioxidant enzymes led to rapid scavenging of
reactive oxygen species (ROS) and consequently less cell damage
in the adapted cells [11].
Nuclear factor erythroid 2-related factor 2 (NFE2L2 or Nrf2)/heme
Oxygenase-1 (HO-1) pathway is an important antioxidative and
protective pathway for cells [12,13]. Nrf2 is sequestered in the cyto-
plasm by Kelch-like ECH-associated protein (Keap1) under un-
stimulated conditions [14–16]. When stimulated, Nrf2 is translocated
into the nucleus and activates the antioxidant response element (ARE)
followed by the induction of HO-1, a downstream target of Nrf2 [17].
In the present study, we focused on the possible role of Nrf2/
HO-1 pathway in RAR. Our results indicated that the priming ra-
diation dose (5 cGy) activated Nrf2 translocation from cytoplasm
to nucleus followed by the upregulation of the HO-1 gene, which
enhanced the antioxidative level of cells to protect cells from a
subsequent exposure to a 2 Gy dose of X-rays.2. Materials and methods
2.1. Cell culture and radiation
Normal human skin ﬁbroblasts AG 1522, which were usednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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minimum essential medium (Gibco, Carlsbad, CA, USA) supple-
mented with 20% fetal bovine serum (Thermo Scientiﬁc Hyclone,
Logan, UT, USA) and 2.0 mM L-glutamine plus 100 μg/ml strepto-
mycin and 100 U/ml penicillin (Gibco, Carlsbad, CA, USA) at 37 °C
in a humidiﬁed 5% CO2 incubator. The culture medium was re-
placed every 2 days until the cells were under full conﬂuence
before irradiation. At that time, 92% of the cells were in the
G0–G1 phases for contact inhibition [20].
The culture medium was replaced with fresh medium before
delivery of the priming dose (1–10 cGy) using an irradiator of
X-ray (SHINVA 600D, Zibo, Shandong, China) at a dose rate of
0.2 Gy/min. The cells were then further cultured for a chosen pre-
deﬁned period before the challenging dose (2 Gy) was applied at a
dose rate of 2.0 Gy/min using the same X-ray irradiator.
2.2. Antibodies
HO-1 primary antibody, β-tubulin primary antibody, lamin B
primary antibody and HPR-conjugated secondary antibody were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA),
Nrf2 primary antibody was purchased from Abcam (Cambridge,
MA, USA).
2.3. MN test
The frequency of MN formation was determined through the
cytokinesis block technique [21]. The cells were trypsinized after
irradiation, and 3104 cells were seeded in each 35 mm culture
dish [20,22]. Cytochalasin B (Sigma, St. Louis, MO, USA) was added
into the culture medium at the ﬁnal concentration of 2.5 μg/ml at
4–6 h post cell seeding. After 48 h incubation, the cells were ﬁxed
with 4% paraformaldehyde (Sigma, St. Louis, MO, USA), stained
with 0.1% acridine orange (Sigma, St. Louis, MO, USA) for 5 min,
and then viewed under a ﬂuorescence microscope (Leica DMI
4000B, Wetzlar, German). At least 1000 binucleate cells were ex-
amined and the frequency of MN formation (r°) was calculated as:
r0¼a/b, where a was the total number of micronucleated cells
scored, and b was the total number of binucleated cells examined.
2.4. Western blot
After irradiation, total protein was extracted with RIPA (Beyo-
time Biotechnology, Shanghai, China) and the concentration was
determined by a BCA protein assay kit (Beyotime Biotechnology,
Shanghai, China). The nuclear and cytosolic protein was extracted
separately with a nuclear and cytoplasmic protein extraction kit
(Shanghaishenggong Biotechnology, Shanghai, China) according to
manufacturer’s protocols. Equal amounts of protein (20 μg) were
resolved by SDS-PAGE and transferred onto PVDF membranes
(Millipore, Billerica, MA, USA). Membranes were blotted with the
primary antibodies and developed after secondary antibody in-
cubation using the ECL kit (Kangweishiji Biotechnology, Beijing,
China) according to the manufacturer’s protocols. For statistical
analysis, a box plot analysis was applied.
2.5. RT-PCR
RT-PCR was performed with Thermo Scientiﬁc Verso 1-step RT-
qPCR Kits (Logan, UT, USA). Gene expression levels were normal-
ized to the level of β-actin. The primers used for PCR ampliﬁcation
are shown as follows: 5′-ATGGATGATGATATCGCCGCG-3′, 5′-
TCTCCATGTCGTCCCAGTTG-3′ (human β-actin) [23], as well as
5′-AAGATTGCCCAGAAAGCCCTGGAC-3′, 5′-AACTGTCGCCACCAGA-
AAGCTGAG-3′ (human HO-1) [24].2.6. RNA interference
Speciﬁc siRNAs for HO-1 (sequence: 5′ UGCUCAA-
CAUCCAGCUCUUtt 3′ and 5′ AAGAGCUGGAUGUUGAGCAtt 3′), Nrf2
(sequence: 5′ GCAUGCUACGUGAUGAAGAtt 3′ and 5′ UCUUCAU-
CACGUAGCAUGCtt 3′) and the control siRNA were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Transfection
medium and transfection reagent were also purchased from Santa
Cruz Biotechnology. Cells were transfected with double-stranded
siRNAs for 24 h with the transfection reagent according to man-
ufacturer’s protocols and recovered in fresh media for 24 h. The
cells were then irradiated and proteins were collected at 12 h after
irradiation for further experiments.
2.7. Measurement of ROS
After irradiation, the cells were stained with 5 μM CellROXs
Green Reagent (Invitrogen, Grand Island, NY, USA) dissolved in
media and then incubated at 37 °C for 30 min. The cells were then
washed with PBS, and the images were captured under a ﬂuor-
escence microscope with a 40 objective (Leica DMI 4000B,
Wetzlar, German). A semi-quantitative analysis of ROS-associated
ﬂuorescent signals was performed with the NIH Image J software.
More than 100 individual cells were randomly selected in each
sample and quantiﬁed. The relative intensities were expressed in
arbitrary units per cell.
2.8. Statistical analysis
Statistical analysis was performed on the data obtained from at
least three independent experiments. The data were presented as
means7SD. The signiﬁcance of variance was determined by AN-
OVA analysis. A p-value smaller than 0.05 between two in-
dependent groups was considered to correspond a statistically
signiﬁcant difference.3. Results
3.1. Time interval and dose effect of RAR
For assessing RAR, the frequency of MN formation of AG 1522
cells were determined. An X-ray dose of 5 cGy was used as a
priming dose as described [25]. AG 1522 cells were primed and
exposed to a 2 Gy challenging dose after the indicated time in-
terval. As shown in Fig. 1, RAR was signiﬁcantly induced after the
application of a priming dose of 5 cGy and the level of RAR de-
monstrated a manner dependent on the time interval between the
initial and challenging radiation doses (Fig. 1A). When the interval
time was 12 h, the amount of RAR reached a peak value when the
MN incidence decreased from 61.573.10 to 38.572.18 per 1000
binucleated cells (BN) (Fig. 1A).
The effect of priming dose was also studied, with the time in-
terval between the application of priming and challenging doses
set as 12 h and using a 2 Gy challenging dose all across. The results
showed a dependence of RAR on the initial priming dose used
(Fig. 1B). Based on these results, in the subsequent experiments on
studying the underlying mechanisms, 5 cGy was chosen as a re-
presentative priming dose, while 12 h was chosen as a re-
presentative time interval between the priming and the challen-
ging exposures.
3.2. Priming dose of radiation promoted HO-1 expression
To determine the effects of priming dose radiation on HO-1
expression, the protein and mRNA levels were detected after 12 h
Fig. 1. Time interval and dose effect of RAR. Effects of time interval and priming dose on RAR. (A) MN test results showing the effect of time interval between the priming
dose and the challenging dose on RAR. Cells were irradiated with 5 cGy of priming dose and then 2 Gy of challenging dose with time intervals of 0, 6, 12, 18 and 24 h.*:
po0.05 compared to 0 h. (B) MN test results showing the effect of priming dose on RAR. Cells were irradiated with 0, 1, 2, 5 and 10 cGy of priming dose and then 2 Gy of
challenging dose with a time interval of 12 h between the priming dose and the challenging dose. *: po0.05 compared to 0 cGy.
Fig. 3. Time-course of HO-1 and Nrf2 expression in cells exposed to a priming dose
of X-ray. (A) Typical western blot images of HO-1, Nrf2 and β-tubulin. (B) Relative
expression of HO-1 at various time points post priming dose irradiation (5 cGy).
(C) Relative expression of Nrf2 at various time points post priming dose irradiation
(5 cGy). Data represent the means7SD of samples from three independent ex-
periments. *: po0.05 compared to control data. Δ: po0.05 compared to 12 h data.
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data showed that HO-1 was signiﬁcantly upregulated by
2.1770.27 and 2.0670.48 fold, respectively, relative to controls
(Fig. 2A and B). AG 1522 cells treated with hemin (Sigma, St. Louis,
MO, USA), which was used as a positive control, also showed a
signiﬁcant up-regulated HO-1 expression at both the protein and
mRNA levels.
3.3. Time-course of HO-1 and Nrf2 expression in cells exposed to
priming dose of radiation
At 0, 6, 12, 18 and 24 h after the priming radiation dose, total
protein of AG 1522 cell was collected and the expressions of HO-1
and Nrf2 were detected with western blot. The results in Fig. 3B
showed that the priming dose induced signiﬁcant increase of HO-1
in a time-dependent manner. The HO-1 expressions were
0.9970.17, 1.6870.1, 2.3570.22, 1.5270.05 and 1.2470.06 folds
of the control (non-irradiated cells), respectively, at 0, 6, 12, 18 and
24 h after the priming radiation dose. This result was consistent
with that for RAR, which was also dependent on the time interval
between priming and challenging radiation dose. The Nrf2 ex-
pression was up-regulated a little bit at 6, 12 and 18 h after theFig. 2. Expression and transcription of HO-1 in cells exposed to priming dose of X-ray. (A) Relative expression of HO-1 protein in cells irradiated by 5 cGy of priming dose.
(B) Relative mRNA abundance of HO-1 in cells irradiated by 5 cGy of priming dose. Data represent the means7SD of samples from three independent experiments. *:
po0.05 compared to control.
Fig. 4. Effects of hemin (10 μM) or Znpp (5 μM) on RAR. Data represent the
means7SD of samples from three independent experiments. *: po0.05.
Fig. 5. Effects of knocking down of HO-1 or Nrf2 on RAR. Data represent the
means7SD of samples from three independent experiments. *: po0.05.
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(Fig. 3C).
3.4. Effects of Hemin and Znpp on RAR
An HO-1 speciﬁc, competitive inhibitor Zinc protoporphyrin IX
(Znpp, Sigma, St. Louis, MO, USA) [26] and HO-1 inducer hemin
[27] were used to determine the role of HO-1 in RAR. Znpp (5 μM)
was added 2 h before irradiation. Hemin (10 μM) was added 24 h
before irradiation. As shown in Fig. 4, pretreatment with Znpp led
to an increase in the yield of MN from 34.872.2 to 58.973.6 per
1000 BN cells in the adapted cells. This result indicated that the
inhibitor of HO-1 could signiﬁcantly attenuate the effect of RAR.
Hemin, was used to mimic the HO-1 upregulation induced by the
priming-dose radiation. The results showed that the hemin pre-
treatment effectively decreased the MN yield caused by a single
2 Gy irradiation from 70.077 to 36.375.3 per 1000 BN cells.
These results implied that the induced HO-1 played an important
role in the induction of RAR.
3.5. Knocking down of HO-1 or Nrf2 by siRNA attenuated RAR
With transfection of cells with HO-1 siRNA or Nrf2 siRNA, HO-1
or Nrf2 was knocked down signiﬁcantly (shown in supplemental
Fig. 1). Consequently, radiation-induced MN formation was de-
tected. Fig. 5 shows that knocking down of HO-1 with its siRNA
results in nearly complete elimination of RAR, as evidence by an
increase in the MN yield from 34.872.2 to 65.973 per 1000 BN
cells. Nrf2, a transcription factor which upregulates HO-1, was also
knocked down with its siRNA. The results showed that knocking
down Nrf2 also increased the MN yield from 34.872.2 to
69.974.7 per 1000 BN cells, which suggested nearly complete
elimination of RAR. It should be noted that control siRNA of HO-1
or Nrf-2 had no signiﬁcant effect on the MN yield. These results
strongly supported that RAR was mediated by HO-1 and Nrf2.
3.6. Priming dose of radiation activated the translocation of Nrf2
from cytoplasm to nucleus
We next determined whether the priming radiation dose in-
duced translocation of Nrf2 from the cytoplasm to the nucleus.
Cytoplasm and nuclear proteins were extracted at 12 h after thepriming-dose irradiation. Western blot was conducted to reveal
the Nrf2 protein levels in both the cytoplasmic and the nuclear
fractions. Fig. 6A shows that a priming dose signiﬁcantly reduces
the Nrf2 protein level to 0.4970.1 folds of the control in the cy-
toplasm. In contrast, the Nrf2 protein level in the nucleus in-
creased to 1.8670.17 folds of the control (Fig. 6B). This result
clearly conﬁrmed that the priming radiation dose activated
translocation of Nrf2 from the cytoplasm to the nucleus. Further-
more, it also demonstrated that transfection of Nrf2 siRNA reduced
the protein expression of Nrf2 in both the cytoplasm and the
nucleus.
3.7. Knock down of Nrf2 down-regulated HO-1 protein level in cell
The effects of knocking down Nrf2 with Nrf2 siRNA on the HO-
1 protein level were examined in both control cells and cells ir-
radiated with a priming dose. The results in Fig. 7 showed that,
with transfection of cells with Nrf2 siRNA, the HO-1 protein levels
were dramatically reduced in both the control cells (from 1 to
0.4370.1 folds of control) and the cells irradiated with the
priming dose (from 2.4270.16 to 0.7870.09 folds of control).
3.8. Nrf2/HO-1 pathway mediated RAR Via regulating ROS
production
To determine the effects of Nrf2 and HO-1 on radiation-induced
ROS production, CellROXs Green Reagent was used to detect ROS.
Fig. 8A shows typical images of ROS under various conditions. As
shown in Fig. 8B, a single irradiation with the challenging dose
(2 Gy) signiﬁcantly induced ROS production to 2.1570.22 folds of
the control. However, adaptation of cells through priming-dose
irradiation effectively reduced the ROS production caused by the
challenging dose, from 2.1570.22 folds of the control down to
1.3170.18 folds. Treatment with hemin showed a similar atte-
nuated effect on ROS production (reduced from 2.1570.22 fold to
1.0370.1 folds of the control) after the challenging-dose irradia-
tion. However, with the treatment of Znpp, ROS production in
adapted cells was increased from 1.3170.18 to 2.0370.19 folds of
the control. As shown in Fig. 8C, when the cells were transfected
with HO-1 siRNA or Nrf2 siRNA, the ROS production induced by
the challenging dose in the adapted cells reverted back to higher
levels (2.0370.15 and 2.0470.1 folds of the control, respectively).
These results clearly illustrated that the priming-dose irradiation
Fig. 6. Translocation of Nrf2 from cytoplasm to nucleus. (A) Nrf2 protein level in cytoplasm. (B) Nrf2 protein level in nucleus. Data represent the means7SD of samples from
three independent experiments. *: po0.05.
Fig. 7. Reduced HO-1 expression in cells transfected by Nrf2 siRNA. Data represent
the means7SD of samples from three independent experiments. *: po0.05.
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dose irradiation via the Nrf2/HO-1 pathway.4. Discussion
RAR, a phenomenon induced by low-dose radiation, has a po-
tential “protective” effect against a subsequent high-dose irradia-
tion [28]. Previous studies elucidated some distinct features of the
protective reaction of human cells against high-dose exposures.
Generally speaking, adaptation is triggered by a very low dose
(25 cGy) and acts in several hours after stimulation. RAR is de-
pendent not only on the rate of priming-dose irradiation but also
on the time interval between priming and challenging dose irra-
diation [25,29]. RAR has also been found to be effective for a re-
latively long time, approximately for three cell cycles [25,30]. Si-
milar to previous studies [25,29], we showed that a prior exposureto 5 cGy X rays could reduce the MN yield in AG1522 cells induced
by a subsequent higher radiation dose (2 Gy). In addition, we de-
monstrated that the optimum time interval between the applica-
tion of priming and challenging doses was 12 h in AG 1522 cells.
However, the extent of RAR was attenuated if the time interval was
prolonged.
Evidences have suggested various possible pathways mediating
RAR. For example, it was reported that the expression and tran-
scription of some speciﬁc genes participating in DNA repair and
cell cycle regulation were required for RAR in human lymphocytes
[31–33]. It was also shown that RAR was inhibited by 3-amino-
benzamide and cycloheximide and there was de novo synthesis of
several proteins in response to a low-dose priming dose [34,35].
Although the initiating signal of RAR was not elucidated, it was
demonstrated that on receiving this unidentiﬁed signal, a subset of
components including various protein kinases and early response
genes regulating transcription machinery of the cell were involved
[36]. Sasaki et al. reported that activation of protein kinase C (PKC)
was required for RAR in murine m5S cells [37]. The intracellular
signal transduction pathway activated by protein phosphorylation
by PKC was a key step induced by low-dose irradiation [38]. A
critical role of the p53 protein in channeling radiation-induced
DNA double-strand breaks (DSBs) into adaptive repair pathways
was also proposed [39].
HO-1, one of the important components of the anti-oxidant
defense system [40,41], is identiﬁed as the 32-kDa stress (heat
shock) protein (HSP32) [42,43]. HO-1 is a microsomal enzyme to
catalyze oxidative breakdown of free heme (a pro-oxidant) mole-
cule to carbon monoxide (CO), Fe2þ , and biliverdin, which is
subsequently reduced to bilirubin by biliverdin reductase [44].
Accumulating evidence had shown the importance of HO-1 ex-
pression in mediating antioxidant, antiinﬂammatory and anti-
apoptotic effects [26,44–46]. It was reported that HO-1 could de-
crease tissue damages induced by lethal-dose irradiation through
modulation of DNA repair [47]. The upregulation of HO-1 was also
reported to mediate adaptive response induced by UVA [48,49].
The membrane damage in human skin ﬁbroblasts induced by UVA
was reduced through pre-irradiation with a low-dose UVA ex-
posure. On the other hand, pretreating cells with HO-1 antisense
oligonucleotide inhibited the UVA-dependent induction of both
the heme oxygenase I enzyme and ferritin, and eliminated the
protective effect of UVA pre-irradiation [48]. In the present work,
we also found that both the levels of HO-1 mRNA and HO-1
Fig. 8. Photomicrographs and quantitative evaluating of ROS in cells. (A) Typical images of ROS results. (B) Effects of hemin or Znpp on ROS production. (C) Effects of
transfection of HO-1 siRNA or Nrf2 siRNA on ROS production. Data represent the means7SD of samples from three independent experiments. *po0.05.
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exposure.
The cytoprotective role of HO-1 was related to the removal of
heme and the production of bilirubin, CO and Fe2þ [50,51]. Bilir-
ubin generated by HO-1 is an antioxidant capable of scavenging
peroxy radicals and inhibiting lipid peroxidation [52]. CO at a low
concentration has been shown to exert biological functions as
diverse as protection against cell death, anti-inﬂammatory effects,
protection against oxidative injury, inhibition of cell proliferation,
neurotransmission and tolerance of organ transplantation [53–55].
The cytoprotective effects of Fe2þ released by HO-1 have been
explained by the fact that Fe2þ promotes gene expression of fer-
ritin, a protein which gives additional cytoprotection against oxi-
dative stress [48]. Furthermore, Fe2þ itself has recently been re-
ported to provide cytoprotection via NF-κB activation [56].
Nrf2 is translocated into the nucleus and activates the anti-
oxidant response element (ARE) under oxidative stress [17]. Nu-
clear Nrf2 can bind to ARE and regulate ARE-mediated antioxidant
enzyme gene expression and induction in response to a variety of
stimuli including antioxidants, xenobiotics, metals, and UV irra-
diation [57]. It is also reported that ionizing radiation activated the
Nrf2-mediated ARE antioxidant response [58]. Activated ARE
mediates expression of a host of antioxidant genes including
quinone oxidoreductase 1, glutathione S-transferase, γ-gluta-
mylcysteine synthetase and HO-1 [59,60]. In this study, we ob-
served an increase in the nuclear fraction while a decrease in the
cytosolic fraction of the Nrf2 protein, indicating a translocation of
Nrf2 from the cytosol to the nucleus. Our results also showed thatRAR was abolished by the administration of Znpp, HO-1 siRNA or
Nrf2 siRNA. The increased expression of antioxidant enzymes after
radiation resulted in rapid scavenging of ROS and consequently
less cell damage. We found that ROS production induced by the
challenging radiation dose was signiﬁcantly increased by Znpp or
transfection of HO-1 siRNA or Nrf2 siRNA. These results suggested
that the priming radiation dose might activate the Nrf2/HO-1
pathway and the cellular antioxidant response.
In summary, our study supported that Nrf2-activated HO-1 up-
regulation played a critical role in RAR. This contributes to the
understanding of the mechanisms underlying RAR.Conﬂict of interest
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